Dr. Ronald J. Renuart, DO

Dr. Renuart practices at Baptist Primary Care Inc in Jacksonville, Florida.

Dr. Renuart's NPI, 1467420778, was assigned on March 11, 2006. Dr. Renuart graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1990. Dr. Renuart holds Florida license OS6119.

Dr. Renuart's primary practice is Baptist Primary Care Inc, at 524 Skymarks Dr, Jacksonville, FL 32218 in Duval County. The practice phone is (904) 376-3707.

Dr. Renuart's primary practice is Baptist Primary Care Inc in Jacksonville, Florida. Dr. Renuart is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is Baptist Primary Care. Dmand AI also links Dr. Renuart to 2 more hospitals, 2 home health agencies and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Renuart practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Renuart's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Renuart is board certified in internal medicine by the American Board of Internal Medicine. Dr. Renuart is licensed in Florida.

Dmand AI lists acid reflux, acute sinusitis, acute skin infection, alcohol use disorders, aneurysm, ankle or foot injury, anxiety and aortic atherosclerois among the conditions Dr. Renuart treats.

CMS data shows 3,128 Medicare services from Dr. Renuart across 20 procedure codes in 2024, for 390 Medicare patients. Medicare paid $158,251 for them. Every service was in an office.

CMS counts 390 Medicare patients who saw Dr. Renuart in 2024. The largest group is 65 to 74, with 177 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Renuart's median patient age at 74, with 35% women.

In 2024, Dr. Renuart wrote 7,052 Medicare Part D claims for 553 patients. 89% of them were for generic drugs. CMS names the drug for 6,369 of them, across 110 drugs with 11 or more claims each, at $370,802 in total drug cost. In 2023, CMS named 6,543 claims across 107 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Renuart for performance year 2024, reported through an alternative payment model (APM). Dr. Renuart accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 43 general payments to Dr. Renuart from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $245.

Dmand AI lists 2 awards for Dr. Renuart, most recently NCQA PCMH in 2015.

Dr. Renuart graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1990. Dr. Renuart is a member of AOA.

Dr. Renuart is in network with 14 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.